Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 17.38
-0.27 (-1.53%)
Jul 31, 2026, 4:08 PM HKT
Sinopharm Group Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 574,272 | 575,168 | 584,508 | 596,570 | 552,148 | 521,051 |
Revenue Growth | -0.80% | -1.60% | -2.02% | 8.04% | 5.97% | 14.16% |
Gross Profit Gross Profit Growth | 41,154 | 41,672 | 44,255 | 48,512 | 47,434 | 44,051 |
Operating Income Operating Income Growth | 17,136 | 17,230 | 17,819 | 22,318 | 22,764 | 20,984 |
Net Income Net Income Growth | 7,112 | 7,155 | 7,050 | 9,054 | 8,526 | 7,759 |
Earnings Per Share EPS Growth | 2.27 | 2.29 | 2.26 | 2.90 | 2.74 | 2.49 |
EPS Growth | -0.00% | 1.37% | -22.10% | 6.02% | 10.02% | 7.63% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Distribution Pharmaceutical Distribution Growth | 435,392 | 444,365 | 441,051 | 406,604 | 389,955 |
Medical Devices Medical Devices Growth | 115,538 | 117,915 | 130,213 | 120,851 | 108,129 |
Retail Pharmacy Retail Pharmacy Growth | 38,383 | 35,981 | 35,689 | 32,979 | 29,059 |
Eliminations Eliminations Growth | -22,997 | -22,860 | -20,769 | -18,496 | -15,913 |
Other Business Other Business Growth | 8,853 | 9,106 | 10,386 | 10,209 | 9,821 |
Total Total Growth | 575,168 | 584,508 | 596,570 | 552,148 | 521,051 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 36,367 | 51,554 | 57,486 | 67,139 | 58,421 | 46,353 |
Total Debt Total Debt Growth | 75,756 | 70,960 | 76,386 | 73,782 | 69,590 | 68,368 |
Net Cash (Debt) Net Cash Growth | -39,389 | -19,407 | -18,900 | -6,643 | -11,169 | -22,016 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -12.58 | -6.22 | -6.06 | -2.13 | -3.58 | -7.05 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 16,246 | 14,138 | 11,546 | 17,173 | 20,964 | 9,308 |
Capital Expenditures CapEx Growth | -1,529 | -1,496 | -1,471 | -1,960 | -2,127 | -2,074 |
Free Cash Flow Free Cash Flow Growth | 14,717 | 12,642 | 10,075 | 15,213 | 18,837 | 7,234 |
Free Cash Flow Growth | -37.20% | 25.49% | -33.78% | -19.23% | 160.38% | -21.85% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 7.17% | 7.25% | 7.57% | 8.13% | 8.59% | 8.45% |
Operating Margin | 2.98% | 3.00% | 3.05% | 3.74% | 4.12% | 4.03% |
Pretax Margin | 2.57% | 2.57% | 2.40% | 3.27% | 3.36% | 3.26% |
Profit Margin | 1.24% | 1.24% | 1.21% | 1.52% | 1.54% | 1.49% |
FCF Margin | 2.56% | 2.20% | 1.72% | 2.55% | 3.41% | 1.39% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.801 | 0.690 | 0.680 | 0.870 | 0.820 | 0.750 |
Dividend Per Share Growth | 6.90% | 1.47% | -21.84% | 6.10% | 9.33% | 8.70% |
Dividend Yield | 4.61% | 4.15% | 3.71% | 5.36% | 5.53% | 6.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.74 | 7.62 | 8.86 | 6.40 | 6.42 | 5.56 |
Forward PE | 6.01 | 6.85 | 7.01 | 5.82 | 6.05 | 4.93 |
P/FCF Ratio | 3.24 | 4.31 | 6.20 | 3.81 | 2.91 | 5.96 |
PS Ratio | 0.08 | 0.10 | 0.11 | 0.10 | 0.10 | 0.08 |